SANDU PHARMACEUTICALS LTD.

Company Profile

SANDU PHARMACEUTICALS LTD. had its IPO on under the ticker symbol SANDUPHQ.

The company operates in the sector and industry. SANDU PHARMACEUTICALS LTD. has a staff strength of 0 employees.

Stock update

Shares of SANDU PHARMACEUTICALS LTD. opened at ₹64.35 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹64.35 - ₹73, and closed at ₹69.18.

This is a +4.34% increase from the previous day's closing price.

A total volume of 77,755 shares were traded at the close of the day’s session.

In the last one week, shares of SANDU PHARMACEUTICALS LTD. have increased by +20.31%.

SANDU PHARMACEUTICALS LTD.'s Key Ratios

SANDU PHARMACEUTICALS LTD. has a market cap of ₹401.42 million, indicating a price to book ratio of 1.6444 and a price to sales ratio of 0.9324.

In the last 12-months SANDU PHARMACEUTICALS LTD.’s revenue was ₹0 with a gross profit of ₹217.38 million and an EBITDA of ₹0. The EBITDA ratio measures SANDU PHARMACEUTICALS LTD.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, SANDU PHARMACEUTICALS LTD.’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q4, SANDU PHARMACEUTICALS LTD.’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

SANDU PHARMACEUTICALS LTD.’s PE and PEG Ratio

Forward PE

0

Trailing PE

91.2882

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into SANDU PHARMACEUTICALS LTD.’s profitability.

SANDU PHARMACEUTICALS LTD. stock is trading at a EV to sales ratio of 0.923 and a EV to EBITDA ratio of 21.1383. Its price to sales ratio in the trailing 12-months stood at 0.9324.

SANDU PHARMACEUTICALS LTD. stock pays annual dividends of ₹ per share, indicating a yield of 0.8% and a payout ratio of 57.79%.

Balance sheet and cash flow metrics

Total Assets

₹517.55 million

Total Liabilities

₹125.57 million

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

57.79%

SANDU PHARMACEUTICALS LTD. ended 2024 with ₹517.55 million in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹517.55 million while shareholder equity stood at ₹382.15 million.

SANDU PHARMACEUTICALS LTD. ended 2024 with ₹0 in deferred long-term liabilities, ₹125.57 million in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹48.05 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.

SANDU PHARMACEUTICALS LTD.’s total current assets stands at ₹259.71 million while long-term investments were ₹0 and short-term investments were ₹13.03 million. Its net receivables were ₹62.73 million compared to accounts payable of ₹70.17 million and inventory worth ₹104.28 million.

In 2024, SANDU PHARMACEUTICALS LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, SANDU PHARMACEUTICALS LTD. paid ₹0.58 in dividends in 2024.

Other key metrics

Current Trading Price

₹69.18

52-Week High

₹78.35

52-Week Low

₹50.25

Analyst Target Price

₹

SANDU PHARMACEUTICALS LTD. stock is currently trading at ₹69.18 per share. It touched a 52-week high of ₹78.35 and a 52-week low of ₹78.35. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹55.61 and 200-day moving average was ₹58.91 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.